Jun

26

2022

What is ruxolitinib?

By William Aird

A

What is ruxolitinib?

An inhibitor of Janus kinase 1 (JAK1) and JAK2 that blocks the cytokine-mediated signaling through JAK/STAT pathways, resulting in inhibition of proinflammatory cytokines. Learn more here.

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.